NGS-Based RNA-Sequencing Market, By Type, By Application, By Component, By Technology, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

NGS-Based RNA-Sequencing Market size was valued at US$ 4,587.82 Million in 2025, expanding at a CAGR of 17.09% from 2026 to 2033.

NGS-based RNA sequencing, usually known as RNA-Seq, is an innovative molecular method that helps next-generation sequencing to study RNA within cells, aiding researchers to identify gene activity, expression levels, and cellular responses in diverse biological circumstances. By allowing millions of RNA fragments to be sequenced simultaneously, it delivers a faster and more detailed view of the transcriptome compared to traditional approaches, where RNA is first converted into a sequencing library before analysis to determine gene expression patterns. This method has become vital in disease research, drug development, and precision medicine due to its capability to show how genes function in real biological systems. The development and implementation of RNA-Seq is inclined by public health significances and government-backed scientific schemes universally. International health bodies like the World Health Organization highlight genomic surveillance for handling infectious diseases, while national institutions like the National Institutes of Health support large-scale transcriptomic research to improve disease understanding. The European Commission also promotes collaborative genomics initiatives across countries to advance personalized healthcare, and the Department of Biotechnology strengthens research infrastructure for sequencing-based studies.

NGS-Based RNA-Sequencing Market- Market Dynamics

Increasing clinical adoption for precision medicine and disease understanding

Rising clinical acceptance for precision medicine and disease understanding is becoming an important factor for the NGS-Based RNA Sequencing market as healthcare systems are gradually affecting from comprehensive treatment methods to more patient-specific decision-making. These sequencing benefits clinicians and researchers to understand how genes are expressed in an individual patient, which makes it probable to identify disease patterns at a much deeper biological level. In the United Kingdom, the Department of Health and Social Care has integrated genomic technologies into the NHS Genomic Medicine Service to improve rare disease and cancer diagnosis using sequencing-based approaches.

Similarly, the Department of Biotechnology in India is adopting clinical genomics and translational research initiatives that direct sequencing data for disease studies and healthcare improvement. On the other side, Illumina delivers sequencing platforms that are widely used in clinical laboratories for gene expression analysis supporting precision medicine workflows. In addition, Thermo Fisher Scientific offers RNA sequencing solutions that assist hospitals and research centers in understanding disease mechanisms and improving treatment strategies.

NGS-Based RNA-Sequencing Market- Segmentation Analysis:

The Global NGS-Based RNA-Sequencing Market is segmented on the basis of Type, Application, Component, Technology, End User, and Region.

Based on type classifications, market is divided into six categories. Among its types, mRNA sequencing reflects its contribution as it widely used approach for studying gene expression outlines across research and clinical studies, offering accuracy, scalability, and determined workflows for transcriptome analysis. Its adoption is supported by its relatively mature workflow and compatibility with most sequencing platforms, making it a standard choice for gene expression profiling. For instance, QIAGEN provides RNA library preparation kits used widely in transcriptome workflows, supporting standardized mRNA sequencing in research laboratories. Likewise, Oxford Nanopore Technologies also offers direct RNA sequencing kits enabling full-length mRNA analysis and real-time transcript detection in biological studies.

Cancer genomics shows notable contribution in this market, according to application. As, it supports understanding of tumor biology through gene expression profiling and detection of transcript variations, assisting researchers study disease development and therapy response in more refined way. Several firms like, Pacific Biosciences provides long-read sequencing capability that enables full-length RNA transcript analysis, improving accuracy in identifying complex cancer-related gene isoforms. In the same way, BGI Genomics supports large-scale cancer transcriptome studies that assist in understanding tumor heterogeneity and guide research in targeted therapy development.

NGS-Based RNA-Sequencing Market- Geographical Insights

From a regional perspective, the market is affected by national genomics policies, biomedical research funding, and increasing emphasis on precision healthcare, where the Asia-Pacific is projected to register meaningful growth as scientific infrastructure and molecular research capabilities continue to reinforce across multiple countries. This region is progressing due to its strong government-backed genomic programs and rising adoption of transcriptomic technologies in disease research and clinical functions. Governments thru Asia-Pacific are actively supporting this growth through structured initiatives. In China, the National Natural Science Foundation of China (NSFC) and the National Health Commission support multi-omics and RNA sequencing research to enhance disease mechanism understanding and biomedical innovation. In Japan, the Ministry of Education, Culture, Sports, Science and Technology (MEXT) along with the Japan Agency for Medical Research and Development (AMED) continues to support life science and genomic medicine initiatives integrating RNA sequencing for advanced research.

In India, the Department of Biotechnology and the Indian Council of Medical Research (ICMR) together supporting genomic surveillance and transcriptomic research for infectious and rare disease studies, firming national research capacity. Furthermore, companies like MedGenome deliver RNA sequencing and multi-omics services to research institutions and pharmaceutical organizations, promoting to applied genomics and data interpretation abilities. This alignment of government-led programs, institutional funding, and private sector contribution supports its development of RNA sequencing applications in this region and promotes broader integration of transcriptomics into healthcare and life sciences development.

UK NGS-Based RNA-Sequencing Market- Country Insights

The United Kingdom determines an evolving environment in this market, as it is reinforced by corresponding national health research programs and strong genomic structure. The government has positioned its focus on integrating sequencing technologies into public health and biomedical research. The Department of Health and Social Care (DHSC) has supported national genomics initiatives through the development of the NHS Genomic Medicine Service, which includes RNA sequencing to enhance rare disease diagnosis and cancer research. Simultaneously, the UK Research and Innovation (UKRI) body, through the Medical Research Council, continues to fund transcriptomics and multi-omics research projects aimed at understanding disease mechanisms at a molecular level. From the industry side, Oxford Nanopore Technologies plays an important role by providing real-time sequencing platforms widely used in RNA sequencing applications for research and clinical studies. The combination of organized government initiatives, public healthcare integration, and its technological capability support continuous progress in RNA sequencing acceptance across research and healthcare systems in the country.

NGS-Based RNA-Sequencing Market- Competitive Landscape:

Amid the rising need for precise viral detection and safer diagnostic systems, the virology specimen collection space is formed by a combination of diagnostic manufacturers and laboratory solution providers. Companies like, Becton, Dickinson and Company, QIAGEN, Copan Italia, Roche Diagnostics, and Puritan Medical Products deliver swabs, transport media, and integrated collection systems that sustenance hospitals, research centers, and public health plans. These participants emphasis on enhancing sample constancy, biosafety standards, and ease of use while ensuring compatibility with advanced molecular testing platforms. Distribution is supported through hospital procurement systems, laboratory supply networks, and direct institutional partnerships, allowing broad accessibility. Recent activity Oxford Nanopore Technologies expanded its RNA sequencing workflow support through enhanced real-time analysis tools in 2025, improving flexibility in transcriptomic studies. Similarly, 10x Genomics strengthened its single-cell RNA sequencing platform by introducing upgraded sample processing and cloud-based data analysis features, reflecting a growing shift toward integrated and scalable genomic research solutions.

Recent Developments:

In January 2026, Illumina announced an expansion of its high-throughput sequencing portfolio with improved RNA-Seq workflows designed to increase speed and data accuracy for large-scale transcriptomics studies. The initiative aims to support growing demand in clinical and research environments. This development reflects a steady move toward faster, more accurate large-scale analysis, supporting efficient research workflows and improved data reliability.

In November 2025, Thermo Fisher Scientific entered into a collaboration with Pfizer to advance RNA-based research workflows, including sequencing applications, for drug development and biomarker discovery. This collaboration reflects a steady move toward integrated research approaches, supporting efficient biomarker discovery and advancing RNA-based drug development capabilities.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NGS-BASED RNA-SEQUENCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Illumina
Thermo Fisher Scientific
Agilent Technologies
QIAGEN
Pacific Biosciences
Oxford Nanopore Technologies
BGI Genomics
Roche
10x Genomics
Bio-Rad Laboratories
PerkinElmer
Eurofins Scientific
Macrogen
Takara Bio
Novogene
Danaher
Becton Dickinson
GenScript
Azenta Life Sciences
Sequenome Genomics
Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

Non-Coding RNA Sequencing (miRNA, lncRNA, circRNA)
Targeted RNA Sequencing
Single-Cell RNA Sequencing (scRNA-Seq)
mRNA Sequencing
Total RNA Sequencing
De Novo Transcriptome Assembly
Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

Cancer Genomics
Precision Medicine
Biomarker Discovery
Plant And Microbial Transcriptomics
Single-Cell Transcriptomics in Immuno-Oncology
Drug Discovery & Development
Disease Mechanism Studies
Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033

Sequencing
Storage & Cloud Bioinformatics
Library Preparation & Sample Processing
Data Analysis & Interpretation
Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

Nanopore Sequencing (Oxford Nanopore)
Sequencing By Synthesis (SBS)
Third-Generation Sequencing (PacBio, ONT)
SOLiD & Pyrosequencing (Legacy/Declining)
Ion Semiconductor Sequencing
Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

Government and Non-Profit Organizations
Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology Companies
Academic & Research Institutions
Clinical & Diagnostic Laboratories
Others

GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV6505

1. NGS-Based RNA-Sequencing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. NGS-Based RNA-Sequencing Market Snippet by Type
- 2.1.2. NGS-Based RNA-Sequencing Market Snippet by Application
- 2.1.3. NGS-Based RNA-Sequencing Market Snippet by Component
- 2.1.4. NGS-Based RNA-Sequencing Market Snippet by Technology
- 2.1.5. NGS-Based RNA-Sequencing Market Snippet by End User
- 2.1.6. NGS-Based RNA-Sequencing Market Snippet by Country
- 2.1.7. NGS-Based RNA-Sequencing Market Snippet by Region
2.2. Competitive Insights

3. NGS-Based RNA-Sequencing Key Market Trends

3.1. NGS-Based RNA-Sequencing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. NGS-Based RNA-Sequencing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. NGS-Based RNA-Sequencing Market Opportunities
3.4. NGS-Based RNA-Sequencing Market Future Trends

4. NGS-Based RNA-Sequencing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. NGS-Based RNA-Sequencing Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. NGS-Based RNA-Sequencing Market Landscape

6.1. NGS-Based RNA-Sequencing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. NGS-Based RNA-Sequencing Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
- 7.1.2. Non-Coding RNA Sequencing (miRNA, lncRNA, circRNA)
- 7.1.3. Targeted RNA Sequencing
- 7.1.4. Single-Cell RNA Sequencing (scRNA-Seq)
- 7.1.5. mRNA Sequencing
- 7.1.6. Total RNA Sequencing
- 7.1.7. De Novo Transcriptome Assembly
- 7.1.8. Others

8. NGS-Based RNA-Sequencing Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. Cancer Genomics
- 8.1.3. Precision Medicine
- 8.1.4. Biomarker Discovery
- 8.1.5. Plant And Microbial Transcriptomics
- 8.1.6. Single-Cell Transcriptomics in Immuno-Oncology
- 8.1.7. Drug Discovery & Development
- 8.1.8. Disease Mechanism Studies
- 8.1.9. Others

9. NGS-Based RNA-Sequencing Market - By Component

9.1. Overview
- 9.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
- 9.1.2. Sequencing
- 9.1.3. Storage & Cloud Bioinformatics
- 9.1.4. Library Preparation & Sample Processing
- 9.1.5. Data Analysis & Interpretation
- 9.1.6. Others

10. NGS-Based RNA-Sequencing Market - By Technology

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 10.1.2. Nanopore Sequencing (Oxford Nanopore)
- 10.1.3. Sequencing By Synthesis (SBS)
- 10.1.4. Third-Generation Sequencing (PacBio, ONT)
- 10.1.5. SOLiD & Pyrosequencing (Legacy/Declining)
- 10.1.6. Ion Semiconductor Sequencing
- 10.1.7. Others

11. NGS-Based RNA-Sequencing Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 11.1.2. Government and Non-Profit Organizations
- 11.1.3. Contract Research Organizations (CROs)
- 11.1.4. Pharmaceutical & Biotechnology Companies
- 11.1.5. Academic & Research Institutions
- 11.1.6. Clinical & Diagnostic Laboratories
- 11.1.7. Others

12. NGS-Based RNA-Sequencing Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. NGS-Based RNA-Sequencing Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. NGS-Based RNA-Sequencing Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.18. Denmark
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.18.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.18.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.18.5. Denmark Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.3.18.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.19. Rest of Europe
  - 12.3.19.1. Overview
  - 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.19.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.19.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.19.5. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.3.19.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. NGS-Based RNA-Sequencing Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.17. Taiwan
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.17.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.17.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.17.5. Taiwan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.4.17.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.18. Vietnam
  - 12.4.18.1. Overview
  - 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.18.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.18.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.18.5. Vietnam Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.4.18.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.19. Rest of APAC
  - 12.4.19.1. Overview
  - 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.19.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.19.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.19.5. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.4.19.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. NGS-Based RNA-Sequencing Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. NGS-Based RNA-Sequencing Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.15. Iran
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.15.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.15.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.15.5. Iran Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.6.15.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.16. Qatar
  - 12.6.16.1. Overview
  - 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.16.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.16.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.16.5. Qatar Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.6.16.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.17. Rest of MEA
  - 12.6.17.1. Overview
  - 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.17.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.17.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.17.5. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
  - 12.6.17.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- NGS-Based RNA-Sequencing Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Illumina
- 13.2.2. Thermo Fisher Scientific
- 13.2.3. Agilent Technologies
- 13.2.4. QIAGEN
- 13.2.5. Pacific Biosciences
- 13.2.6. Oxford Nanopore Technologies
- 13.2.7. BGI Genomics
- 13.2.8. Roche
- 13.2.9. 10x Genomics
- 13.2.10. Bio-Rad Laboratories
- 13.2.11. PerkinElmer
- 13.2.12. Eurofins Scientific
- 13.2.13. Macrogen
- 13.2.14. Takara Bio
- 13.2.15. Novogene
- 13.2.16. Danaher
- 13.2.17. Becton Dickinson
- 13.2.18. GenScript
- 13.2.19. Azenta Life Sciences
- 13.2.20. Sequenome Genomics
- 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us